MedPath

Preliminary clinical evaluation of Ziziphus jujuba mill. fruit on treatment of dyslipidemia in adolescents

Not Applicable
Conditions
Dyslipidemia.
Hyperlipidaemia, unspecified
Registration Number
IRCT201109092306N1
Lead Sponsor
Vice chancellor for research, Isfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
68
Inclusion Criteria

1)adolescents between 12 to 18 years old that have at least one of these criteria:
a: triglyceride more than 90 percentile b: total cholesterol more than 90 percentile c: LDL more than 90 percentile d:HDL less than 10 percentile
2) Not using tobacco
3) No history of alcohol consumption or drug abuse
4) No history of metabolic diseases like diabetes, thyroid gland dysfunction, nephrotic syndrome, chronic pancreatitis, liver and gall bladder diseases that affects lipid profiles
5) Not using drugs which affect lipid profiles like statins and hormonal pills like estrogens, progestrones and oral contraceptives.
Exclusion criteria:
1) Lack of patient’s compliance with drug regimens at least for one week.
2) Pregnancy and lactation
3) Drug sensitivity
4) Suffering from any diseases which interact with lipid profiles
5) Intake of any kind of drugs or other compounds lowering lipid profile like corticosteroids, androgens, estrogenes, progestines, thiazides, beta blockers and thyroid hormones

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Triglyceride. Timepoint: Before intervention, one month after intervention. Method of measurement: mg/dl through using laboratory kit.;Total cholesterol. Timepoint: Before intervention, one month after intervention. Method of measurement: mg/dl through using laboratory kit.;LDL. Timepoint: Before intervention, one month after intervention. Method of measurement: mg/dl through using laboratory kit.;HDL. Timepoint: Before intervention, one month after intervention. Method of measurement: mg/dl through using laboratory kit.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath